NasdaqGS - Nasdaq Real Time Price USD

Option Care Health, Inc. (OPCH)

28.73 -0.31 (-1.05%)
As of 11:31 AM EDT. Market Open.
Loading Chart for OPCH
DELL
  • Previous Close 29.03
  • Open 28.93
  • Bid 24.87 x 100
  • Ask 33.29 x 100
  • Day's Range 28.70 - 29.02
  • 52 Week Range 26.17 - 35.74
  • Volume 192,737
  • Avg. Volume 1,302,845
  • Market Cap (intraday) 4.993B
  • Beta (5Y Monthly) 1.32
  • PE Ratio (TTM) 18.77
  • EPS (TTM) 1.53
  • Earnings Date Jul 25, 2024 - Jul 29, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 39.57

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.

www.optioncarehealth.com

7,500

Full Time Employees

December 31

Fiscal Year Ends

Recent News: OPCH

Performance Overview: OPCH

Trailing total returns as of 5/23/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

OPCH
14.74%
S&P 500
11.47%

1-Year Return

OPCH
2.19%
S&P 500
26.82%

3-Year Return

OPCH
53.53%
S&P 500
27.94%

5-Year Return

OPCH
230.93%
S&P 500
86.16%

Compare To: OPCH

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: OPCH

Valuation Measures

Annual
As of 5/22/2024
  • Market Cap

    5.05B

  • Enterprise Value

    6.00B

  • Trailing P/E

    18.97

  • Forward P/E

    25.25

  • PEG Ratio (5yr expected)

    2.52

  • Price/Sales (ttm)

    1.17

  • Price/Book (mrq)

    3.53

  • Enterprise Value/Revenue

    1.35

  • Enterprise Value/EBITDA

    12.64

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.15%

  • Return on Assets (ttm)

    6.21%

  • Return on Equity (ttm)

    19.62%

  • Revenue (ttm)

    4.43B

  • Net Income Avi to Common (ttm)

    272.67M

  • Diluted EPS (ttm)

    1.53

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    229.93M

  • Total Debt/Equity (mrq)

    81.92%

  • Levered Free Cash Flow (ttm)

    65.5M

Research Analysis: OPCH

Company Insights: OPCH

Research Reports: OPCH

People Also Watch